Barbeira, A. N. et al. Exploring the phenotypic consequences of tissue specific gene expression variation inferred from GWAS summary statistics. Nat. Commun. 9, 1825 (2018).
Moore, C. et al. The INTERVAL trial to determine whether intervals between blood donations can be safely and acceptably decreased to optimise blood supply: study protocol for a randomised controlled trial. Trials 15, 363 (2014).
Bycroft, C. et al. The UK Biobank resource with deep phenotyping and genomic data. Nature 562, 203–209 (2018).
Ritchie, S. C. et al. Integrative analysis of the plasma proteome and polygenic risk of cardiometabolic diseases. Nat. Metab. 3, 1476–1483 (2021).
Lambert, S. A. et al. The Polygenic Score Catalog as an open database for reproducibility and systematic evaluation. Nat. Genet. 53, 420–425 (2021).
Adeyemo, A. et al. Responsible use of polygenic risk scores in the clinic: potential benefits, risks and gaps. Nat. Med. 27, 1876–1884 (2021).
Xu, Y. et al. Machine learning optimized polygenic scores for blood cell traits identify sex-specific trajectories and genetic correlations with disease. Cell Genomics 2, 100086 (2022).
Gusev, A. et al. Integrative approaches for large-scale transcriptome-wide association studies. Nat. Genet. 48, 245–252 (2016).
Gamazon, E. R. et al. A gene-based association method for mapping traits using reference transcriptome data. Nat. Genet. 47, 1091–1098 (2015).
Mosley, J. D. et al. Probing the virtual proteome to identify novel disease biomarkers. Circulation 138, 2469–2481 (2018).
Hutcheon, J. A., Chiolero, A. & Hanley, J. A. Random measurement error and regression dilution bias. Br. Med. J. 340, 1402–1406 (2010).
Pividori, M., Schoettler, N., Nicolae, D. L., Ober, C. & Im, H. K. Shared and distinct genetic risk factors for childhood-onset and adult-onset asthma: genome-wide and transcriptome-wide studies. Lancet Respir. Med. 7, 509–522 (2019).
Lannelongue, L., Grealey, J., Bateman, A. & Inouye, M. Ten simple rules to make your computing more environmentally sustainable. PLoS Comput. Biol. 17, e1009324 (2021).
Berisa, T. & Pickrell, J. K. Approximately independent linkage disequilibrium blocks in human populations. Bioinformatics 32, 283–285 (2016).
Pietzner, M. et al. Mapping the proteo-genomic convergence of human diseases. Science 374, eabj1541 (2021).
Igl, W., Johansson, A. & Gyllensten, U. The Northern Swedish Population Health Study (NSPHS)—a paradigmatic study in a rural population combining community health and basic research. Rural Remote Health 10, 1363 (2010).
McQuillan, R. et al. Runs of homozygosity in European populations. Am. J. Hum. Genet. 83, 359 (2008).
Kerr, S. M. et al. An actionable KCNH2 Long QT Syndrome variant detected by sequence and haplotype analysis in a population research cohort. Sci. Rep. 9, 10964 (2019).
Tan, K. H. X. et al. Cohort profile: the Singapore Multi-Ethnic Cohort (MEC) study. Int. J. Epidemiol. 47, 699–699j (2018).
Katz, D. H. et al. Whole genome sequence analysis of the plasma proteome in black adults provides novel insights into cardiovascular disease. Circulation 145, 357–370 (2021).
Fabregat, A. et al. The Reactome Pathway Knowledgebase. Nucleic Acids Res. 46, D649–D655 (2018).
Patrick, et al. Mapping ICD-10 and ICD-10-CM codes to phecodes: workflow development and initial evaluation. JMIR Med. Inf. 7, e14325 (2019).
Sarwar, N. et al. Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet 379, 1205–1213 (2012).
Haiman, C. A. et al. Levels of β-microseminoprotein in blood and risk of prostate cancer in multiple populations. J. Natl Cancer Inst. 105, 237–243 (2013).
Ding, E. L. et al. Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N. Engl. J. Med. 361, 1152–1163 (2009).
Saini, V. Molecular mechanisms of insulin resistance in type 2 diabetes mellitus. World J. Diabetes 1, 68 (2010).
Qi, L. et al. Genetic variants in ABO blood group region, plasma soluble E-selectin levels and risk of type 2 diabetes. Hum. Mol. Genet. 19, 1856–1862 (2010).
Peters, M. C. et al. Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts. Lancet Respir. Med. 4, 574–584 (2016).
Banaganapalli, B. et al. Exploring celiac disease candidate pathways by global gene expression profiling and gene network cluster analysis. Sci. Rep. 10, 16290 (2020).
Gagliano Taliun, S. A. et al. Exploring and visualizing large-scale genetic associations by using PheWeb. Nat. Genet. 52, 550–552 (2020).
Kim, H. I. et al. Fine mapping and functional analysis reveal a role of SLC22A1 in acylcarnitine transport. Am. J. Hum. Genet. 101, 489 (2017).
Tamai, I. Pharmacological and pathophysiological roles of carnitine/organic cation transporters (OCTNs: SLC22A4, SLC22A5 and Slc22a21). Biopharm. Drug Dispos. 34, 29–44 (2013).
Chang, H. B., Gao, X., Nepomuceno, R., Hu, S. & Sun, D. Na+/H+ exchanger in the regulation of platelet activation and paradoxical effects of cariporide. Exp. Neurol. 272, 11–16 (2015).
de Vries, P. S. et al. Whole-genome sequencing study of serum peptide levels: the Atherosclerosis Risk in Communities study. Hum. Mol. Genet. 26, 3442–3450 (2017).
Babaev, V. R. et al. Loss of 2 Akt (protein kinase B) isoforms in hematopoietic cells diminished monocyte and macrophage survival and reduces atherosclerosis in Ldl receptor-null mice. Arterioscler. Thromb. Vasc. Biol. 39, 156–169 (2019).
Miteva, K. et al. Cardiotrophin-1 deficiency abrogates atherosclerosis progression. Sci. Rep. 10, 5791 (2020).
Agrawal, S. et al. Signal transducer and activator of transcription 1 is required for optimal foam cell formation and atherosclerotic lesion development. Circulation 115, 2939–2947 (2007).
Peltola, K. J. et al. Pim-1 kinase inhibits STAT5-dependent transcription via its interactions with SOCS1 and SOCS3. Blood 103, 3744–3750 (2004).
Khor, C. C. et al. CISH and susceptibility to infectious diseases. N. Engl. J. Med. 362, 2092–2101 (2010).
Baldini, C., Moriconi, F. R., Galimberti, S., Libby, P. & De Caterina, R. The JAK–STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms. Eur. Heart J. 42, 4389–4400 (2021).
Skah, S., Uchuya-Castillo, J., Sirakov, M. & Plateroti, M. The thyroid hormone nuclear receptors and the Wnt/β-catenin pathway: an intriguing liaison. Dev. Biol. 422, 71–82 (2017).
Chen, G. et al. Regulation of GSK-3β in the proliferation and apoptosis of human thyrocytes investigated using a GSK-3β-targeting RNAi adenovirus expression vector: involvement the Wnt/β-catenin pathway. Mol. Biol. Rep. 37, 2773–2779 (2009).
Ely, K. A., Bischoff, L. A. & Weiss, V. L. Wnt signaling in thyroid homeostasis and carcinogenesis. Genes 9, 204 (2018).
Haerlingen, B. et al. Small-molecule screening in zebrafish embryos identifies signaling pathways regulating early thyroid development. Thyroid 29, 1683–1703 (2019).
Narumi, S. et al. GWAS of thyroid dysgenesis identifies a risk locus at 2q33.3 linked to regulation of Wnt signaling. Hum. Mol. Genet. 31, 3967–3974 (2022).
Xu, D. et al. USP25 regulates Wnt signaling by controlling the stability of tankyrases. Genes Dev. 31, 1024–1035 (2017).
Lin, D. et al. Induction of USP25 by viral infection promotes innate antiviral responses by mediating the stabilization of TRAF3 and TRAF6. Proc. Natl Acad. Sci. USA 112, 11324–11329 (2015).
Nelson, J. K. et al. USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic cancer. Nat. Commun. 13, 2070 (2022).
Blount, J. R., Burr, A. A., Denuc, A., Marfany, G. & Todi, S. V. Ubiquitin-specific protease 25 functions in endoplasmic reticulum-associated degradation. PLoS One 7, e36542 (2012).
Martin, A. R. et al. Clinical use of current polygenic risk scores may exacerbate health disparities. Nat. Genet. 51, 584–591 (2019).
Chang, C. C. et al. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience 4, 7 (2015).
The 1000 Genomes Project Consortium. A global reference for human genetic variation. Nature 526, 68–74 (2015).
Astle, W. J. et al. The allelic landscape of human blood cell trait variation and links to common complex disease. Cell 167, 1415–1429 (2016).
Sun, B. B. et al. Genomic atlas of the human plasma proteome. Nature 558, 73–79 (2018).
Lundberg, M., Eriksson, A., Tran, B., Assarsson, E. & Fredriksson, S. Homogeneous antibody-based proximity extension assays provide sensitive and specific detection of low-abundant proteins in human blood. Nucleic Acids Res. 39, e102 (2011).
Folkersen, L. et al. Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals. Nat. Metab. 2, 1135–1148 (2020).
Surendran, P. et al. Rare and common genetic determinants of metabolic individuality and their effects on human health. Nat. Med. 28, 2321–2332 (2022).
Karjalainen, M. K. et al. Genome-wide characterization of circulating metabolic biomarkers reveals substantial pleiotropy and novel disease pathways. Preprint at medRxiv https://doi.org/10.1101/2022.10.20.22281089 (2022).
Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923–930 (2014).
Fort, A. et al. MBV: a method to solve sample mislabeling and detect technical bias in large combined genotype and sequencing assay datasets. Bioinformatics 33, 1895–1897 (2017).
Robinson, M. D. & Oshlack, A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 11, R25 (2010).
Stegle, O., Parts, L., Piipari, M., Winn, J. & Durbin, R. Using probabilistic estimation of expression residuals (PEER) to obtain increased power and interpretability of gene expression analyses. Nat. Protoc. 7, 500–507 (2012).
Taylor-Weiner, A. et al. Scaling computational genomics to millions of individuals with GPUs. Genome Biol. 20, 228 (2019).
Stacklies, W., Redestig, H., Scholz, M., Walther, D. & Selbig, J. pcaMethods—a bioconductor package providing PCA methods for incomplete data. Bioinformatics 23, 1164–1167 (2007).
Pietzner, M. et al. Genetic architecture of host proteins involved in SARS-CoV-2 infection. Nat. Commun. 11, 6397 (2020).
Bretherick, A. D. et al. Linking protein to phenotype with Mendelian randomization detects 38 proteins with causal roles in human diseases and traits. PLoS Genet. 16, e1008785 (2020).
Kierczak, M. et al. Contribution of rare whole-genome sequencing variants to plasma protein levels and the missing heritability. Nat. Commun. 13, 2532 (2022).
Ritchie, S. C. et al. Quality control and removal of technical variation of NMR metabolic biomarker data in ~120,000 UK Biobank participants. Sci. Data 10, 64 (2023).
Wong, E. et al. The Singapore National Precision Medicine strategy. Nat. Genet. 55, 178–186 (2023).
Zhang, F. et al. Ancestry-agnostic estimation of DNA sample contamination from sequence reads. Genome Res. 30, 185–194 (2020).
Taylor, H. A. J. et al. Toward resolution of cardiovascular health disparities in African Americans: design and methods of the Jackson Heart Study. Ethn. Dis. 15, S6-4-17 (2005).
Taliun, D. et al. Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program. Nature 590, 290–299 (2021).
Ngo, D. et al. Aptamer-based proteomic profiling reveals novel candidate biomarkers and pathways in cardiovascular disease. Circulation 134, 270–285 (2016).
Torkamani, A., Wineinger, N. E. & Topol, E. J. The personal and clinical utility of polygenic risk scores. Nat. Rev. Genet. 19, 581–590 (2018).
Chatterjee, N., Shi, J. & Garcia-Closas, M. Developing and evaluating polygenic risk prediction models for stratified disease prevention. Nat. Rev. Genet. 17, 392–406 (2016).
Okser, S. et al. Regularized machine learning in the genetic prediction of complex traits. PLoS Genet. 10, e1004754 (2014).
Vilhjálmsson, B. J. et al. Modeling linkage disequilibrium increases accuracy of polygenic risk scores. Am. J. Hum. Genet. 97, 576–592 (2015).
Bishop, C. M. Pattern Recognition and Machine Learning (Springer, 2006).
Tipping, M. E. Sparse Bayesian learning and the relevance vector machine. J. Mach. Learn. Res. 1, 211–244 (2001).
Privé, F., Arbel, J. & Vilhjálmsson, B. J. LDpred2: better, faster, stronger. Bioinformatics 36, 5424–5431 (2021).
Pietzner, M. et al. Synergistic insights into human health from aptamer- and antibody-based proteomic profiling. Nat. Commun. 12, 6822 (2021).
Davidson-Pilon, C. lifelines: survival analysis in Python. J. Open Source Softw. 4, 1317 (2019).
Lannelongue, L., Grealey, J. & Inouye, M. Green algorithms: quantifying the carbon footprint of computation. Adv. Sci. 8, 2100707 (2021).
Di Angelantonio, E. et al. Efficiency and safety of varying the frequency of whole blood donation (INTERVAL): a randomised trial of 45 000 donors. Lancet 390, 2360–2371 (2017).
More News
Judge dismisses superconductivity physicist’s lawsuit against university
Future of Humanity Institute shuts: what’s next for ‘deep future’ research?
Star Formation Shut Down by Multiphase Gas Outflow in a Galaxy at a Redshift of 2.45 – Nature